라디오파 절제 기기 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 구성요소 유형별, 용도별, 최종 용도별, 지역별, 경쟁별(2020-2030년)

The Global Radiofrequency Ablation Devices Market will grow from USD 4.33 Billion in 2024 to USD 8.43 Billion by 2030 at a 11.74% CAGR. Radiofrequency ablation (RFA) devices employ high-frequency electrical currents to generate controlled heat, precisely ablating targeted pathological tissues without requiring open surgical intervention. These devices are primarily utilized across diverse medical fields, including oncology for tumor treatment, pain management for chronic conditions, and cardiology for addressing cardiac arrhythmias.

Key Market Drivers

The increasing incidence of chronic and cardiovascular diseases significantly drives the global radiofrequency ablation devices market. Conditions like various cancers and cardiac arrhythmias require precise tissue destruction for effective treatment. According to the World Health Organization and the International Agency for Research on Cancer (IARC), in their February 2024 'Global cancer burden growing, amidst mounting need for services' report, an estimated 20 million new cancer cases were recorded globally in 2022, indicating a substantial patient population needing intervention.

Key Market Challenges

A significant challenge impeding the expansion of the global radiofrequency ablation devices market is the substantial capital investment required for acquiring specialized RFA systems. This considerable initial expenditure directly limits the widespread adoption of these advanced medical tools, particularly within healthcare institutions facing budgetary restrictions. Such financial constraints are especially pronounced in emerging economies, where resources for high-cost medical equipment purchases may be scarce.

Key Market Trends

The expansion of RF ablation procedures to outpatient settings represents a significant shift towards more efficient and patient-centric healthcare delivery. By transitioning these procedures from traditional inpatient hospital environments to ambulatory surgery centers, healthcare providers can reduce operational overheads while offering patients benefits such as decreased recovery times and shorter hospital stays. This trend is bolstered by ongoing technological advancements that make RF ablation less invasive and increasingly suitable for outpatient environments.

Key Market Players

• Boston Scientific Corporation
• Medtronic plc
• Stryker Corporation
• Abbott Laboratories, Inc.
• Smith & Nephew PLC
• Johnson & Johnson
• AngioDynamics Inc

Report Scope:

In this report, the Global Radiofrequency Ablation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Radiofrequency Ablation Devices Market , By Component Type:

• Disposable equipment
• Capital equipment
• Reusable equipment

Radiofrequency Ablation Devices Market , By Application:

• Surgical oncology
• Cardiology & cardiac rhythm management
• Cosmetology
• Gynecology
• Pain management

Radiofrequency Ablation Devices Market , By End Use:

• Hospitals
• Ambulatory surgery centers
• Research laboratories
• Others

Radiofrequency Ablation Devices Market , By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Radiofrequency Ablation Devices Market .

Available Customizations:

Global Radiofrequency Ablation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Radiofrequency Ablation Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component Type (Disposable equipment, Capital equipment, Reusable equipment)
  • 5.2.2. By Application (Surgical oncology, Cardiology & cardiac rhythm management, Cosmetology, Gynecology, Pain management)
  • 5.2.3. By End Use (Hospitals, Ambulatory surgery centers, Research laboratories, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Radiofrequency Ablation Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component Type
  • 6.2.2. By Application
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Radiofrequency Ablation Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Radiofrequency Ablation Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Radiofrequency Ablation Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End Use

7. Europe Radiofrequency Ablation Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component Type
  • 7.2.2. By Application
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Radiofrequency Ablation Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Radiofrequency Ablation Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Radiofrequency Ablation Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Radiofrequency Ablation Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Radiofrequency Ablation Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End Use

8. Asia Pacific Radiofrequency Ablation Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component Type
  • 8.2.2. By Application
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Radiofrequency Ablation Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Radiofrequency Ablation Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Radiofrequency Ablation Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Radiofrequency Ablation Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Radiofrequency Ablation Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Radiofrequency Ablation Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component Type
  • 9.2.2. By Application
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Radiofrequency Ablation Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Radiofrequency Ablation Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Radiofrequency Ablation Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End Use

10. South America Radiofrequency Ablation Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component Type
  • 10.2.2. By Application
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Radiofrequency Ablation Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Radiofrequency Ablation Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Radiofrequency Ablation Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Radiofrequency Ablation Devices Market : SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boston Scientific Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medtronic plc
• 15.3. Stryker Corporation
• 15.4. Abbott Laboratories, Inc.
• 15.5. Smith & Nephew PLC
• 15.6. Johnson & Johnson
• 15.7. AngioDynamics Inc

16. Strategic Recommendations

17. About Us & Disclaimer